Benzene in Acne Products: Clinical Implications, Risks, and Regulatory Response

Highlights

• Independent laboratory testing revealed high levels of benzene, a carcinogen, in several benzoyl peroxide acne products, far exceeding the FDA’s acceptable limit.
• The FDA and manufacturers responded with recalls and public advisories, but debate remains regarding the adequacy of current regulatory actions.
• Recent studies suggest that storage conditions, especially temperature, and product formulation influence benzene formation.
• Despite benzene concerns, there is currently no epidemiological evidence linking benzoyl peroxide acne treatment to increased benzene-related cancer risk.

Clinical Background and Disease Burden